EBM Technologies Incorporated (TPEX:8409)
Taiwan · Delayed Price · Currency is TWD 20.70
+0.10 (0.49%)
Apr 2, 2026, 1:30 PM CST
EBM Technologies Market Cap
EBM Technologies has a market cap or net worth of 662.4 million as of April 2, 2026. Its market cap has decreased by -17.03% in one year.
Market Cap
662.40M
Enterprise Value
596.52M
Revenue
253.11M
Ranking
n/a
PE Ratio
86.25
Stock Price
20.70
Market Cap Chart
Since April 13, 2010, EBM Technologies's market cap has decreased from 882.35M to 662.40M, a decrease of -24.93%. That is a compound annual growth rate of -1.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 662.40M | -4.83% |
| Dec 31, 2025 | 696.00M | -7.45% |
| Dec 31, 2024 | 752.00M | -6.00% |
| Dec 29, 2023 | 800.00M | 31.93% |
| Dec 30, 2022 | 606.40M | 6.16% |
| Dec 30, 2021 | 571.20M | 11.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 234.57B |
| Caliway Biopharmaceuticals | 148.78B |
| Bora Pharmaceuticals | 57.02B |
| Lotus Pharmaceutical | 56.77B |
| BioLASCO Taiwan | 737.63M |
| Sofiva Genomics | 727.70M |
| SynCore Biotechnology Co.,Ltd | 719.12M |
| Ttbio | 683.64M |